- Telehealth Visits
- Insurance plan information
Rutvij Pandya, MD
He | Him | HisFamily Medicine- Telehealth Visits
- Insurance plan information
Rutvij Pandya, MD
He | Him | HisFamily Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Rutvij Pandya is a family medicine doctor who provides primary care. His specialties include geriatrics, palliative care, chronic disease management, preventive medicine and healthy aging.
Pandya earned his medical degree at the University of Maryland School of Medicine. He also completed a residency in family medicine there, receiving the 2023 Resident of the Year Award. He completed a fellowship in geriatric medicine at the University of Maryland Medical Center, with training at the Baltimore Veterans Affairs Medical Center.
Pandya feels fortunate to have had great mentors who were his role models for the kind of primary care provider and geriatrician he wanted to become. He is also passionate about the intersection of medicine and the humanities.
In his free time, Pandya enjoys getting to know San Francisco through road and trail running as well as exploring the city's architecture.
Education & training
Board certification
- Geriatric Medicine, American Board of Family Medicine
- Family Medicine, American Board of Family Medicine
Fellowship
- Geriatric Medicine, University of Maryland Medicine
Residency
- Family Medicine, University of Maryland Medicine
Degree
- MD, University of Maryland School of Medicine
My expertise
Specialties
- Family Medicine
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225175%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225175%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.